tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (DE:9Y4)
FRANKFURT:9Y4
Germany Market

Ryvu Therapeutics SA (9Y4) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Ryvu Therapeutics SA’s (9Y4) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Ryvu Therapeutics SA is a Buy.
Ryvu Therapeutics SA’s (9Y4) 20-Day exponential moving average is 5.88, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Sell.
Ryvu Therapeutics SA’s (9Y4) 50-Day exponential moving average is 5.98, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Sell.

Ryvu Therapeutics SA (9Y4) Pivot Points

Mar 14, 2026, 02:33 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.82
5.82
5.82
5.82
5.82
5.82
5.82
Fibonacci
5.82
5.82
5.82
5.82
5.82
5.82
5.82
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ryvu Therapeutics SA (9Y4) Moving Averages

Mar 14, 2026, 02:33 PM
Period
Simple
Exponential
MA5
5.80Sell
5.80Sell
MA10
5.85Sell
5.84Sell
MA20
5.89Sell
5.88Sell
MA50
6.05Sell
5.98Sell
MA100
6.01Sell
6.08Sell
MA200
6.40Sell
6.32Sell
Ryvu Therapeutics SA’s (9Y4) 10-Day exponential moving average is 5.84, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Sell.
Ryvu Therapeutics SA’s (9Y4) 100-Day exponential moving average is 6.08, while Ryvu Therapeutics SA’s (9Y4) share price is €6.35, making it a Sell.
Ryvu Therapeutics SA’s (9Y4) stock price is €6.35 and Ryvu Therapeutics SA’s (9Y4) 50-day simple moving average is 6.05, creating a Sell signal.
Ryvu Therapeutics SA’s (9Y4) stock price is €6.35 and Ryvu Therapeutics SA’s (9Y4) 100-day simple moving average is 6.01, creating a Sell signal.
Ryvu Therapeutics SA’s (9Y4) stock price is €6.35 and Ryvu Therapeutics SA’s (9Y4) 200-day simple moving average is 6.40, creating a Sell signal.

Ryvu Therapeutics SA (9Y4) Technical Indicators

Mar 14, 2026, 02:33 PM
Name
Value
Implied Action
RSI (14)
45.85
Neutral
STOCH (9,6)
24.31
Neutral
STOCHRSI (14)
21.21
Neutral
MACD (12,26)
-0.06
Buy
ADX (14)
8.63
Buy
Williams %R
-72.73
Buy
CCI (14)
-95.69
Neutral
ATR (14)
0.13
-
Ultimate Oscillator
40.33
Neutral
ROC
-3.03
Sell
Ryvu Therapeutics SA’s (9Y4) Relative Strength Index (RSI) is 45.85, creating a Neutral signal.
Ryvu Therapeutics SA’s (9Y4) Trend Strength Indicator (ADX) is 8.63, creating a Buy signal.
Ryvu Therapeutics SA’s (9Y4) Commodity Channel Index (CCI) is -95.69, creating a Neutral signal.
Ryvu Therapeutics SA’s (9Y4) Price Rate of Change (ROC) is -3.03, creating a Sell signal.

FAQ

Is 9Y4 a Buy, Hold, or Sell?
Based on 9Y4’s technical indicators, 9Y4 is a Strong Sell.
    What is 9Y4’s RSI (14)?
    9Y4’s RSI (14) is 45.85, which suggests 9Y4 is a Neutral.
      What is 9Y4’s MACD?
      9Y4’s MACD is -0.06, which suggests 9Y4 is a Buy.
        What is 9Y4’s 5-day moving average?
        9Y4’s 5-day moving average is 5.80, which suggests 9Y4 is a Sell.
          What is 9Y4’s 20-day moving average?
          9Y4 20-day moving average is 5.89, which suggests 9Y4 is a Sell.
            What is 9Y4’s 50-day moving average?
            9Y4’s 50-day moving average is 6.05, which suggests 9Y4 is a Sell.
              What is 9Y4’s 200-day moving average?
              9Y4’s 200-day moving average is 6.40, which suggests 9Y4 is a Sell.
                What is 9Y4’s Williams % R (14)?
                9Y4’s Williams % R (14) is -72.73, which suggests 9Y4 is a Buy.
                  What is 9Y4’s CCI (14)?
                  9Y4’s CCI (14) is -95.69, which suggests 9Y4 is a Neutral.
                    What is the share price of Ryvu Therapeutics SA?